• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • Subscribe newsletter
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

WHO Academy, Lyonateliers 2/3/4/

Macron, Ghebreyesus break ground for new WHO Academy in Lyon

, 27 September 2021/in E-News /by panglobal
WHO Academy, Lyon

A 3D rendering of the Library at the WHO Academy in Lyon, France. © ateliers 2/3/4/

 

 

French president Emmanuel Macron, and WHO Director-General Dr Tedros Adhanom Ghebreyesus, today broke ground for the WHO Academy’s campus in the French city of Lyon.

The event fulfils a commitment by the two leaders to establish a WHO Academy in Lyon’s bio-medical district to meet the needs of WHO Member States and a growing global health workforce to provide for expanded access to life-long learning, health guidance and competency-building.

Designed for collaborative learning

When it opens in 2024, the WHO Academy campus in Lyon will have high-tech and people-centred spaces designed for collaborative learning, educational research and innovation. It will also host a world-class health emergencies simulation centre that will use advanced technologies to enable health workers to sharpen their competencies amid realistic scenarios including mass casualties and disease outbreaks.

WHO Academy, Lyon

A 3D rendering of the exterior of the WHO Academy in Lyon, France. © ateliers 2/3/4/

During today’s event at Lyon’s Cité Internationale, President Macron and Dr Tedros reviewed an architectural model of the building and talked via video-link with health workers who have participated in the Academy’s Mass Casualty Management programme, which is already operating in several countries including France, Greece, Afghanistan, Ethiopia and Somalia.

The quickening pace of scientific discovery and advancement of technology is making it more difficult for health workers, policy makers and other public health practitioners to keep up with evidence-based health practice and policy. As a result, it often takes more than a decade to put important life-saving guidelines into practice.

From its campus in Lyon, the Academy will offer multilingual, personalized learning programmes in digital, in-person and blended formats, deploying the latest evidence-based health guidance, state-of-the-art learning technologies and advancements in the science of adult learning.

Resilience during a health crisis

“The ambitions of the WHO Academy are not modest: to transform lifelong learning in health globally,” said Dr Tedros. “The COVID-19 pandemic is a powerful demonstration of the value of health workers, and why they need the most up-to-date information, competencies and tools to keep their communities healthy and safe.”

He added: “The WHO Academy is an investment in health, education, knowledge and technology, but ultimately it’s an investment in people, and in a healthier, safer, fairer future.”

“The quality of the health workforce is the key to resilience during a health crisis,” said President Macron. “Investing in health systems is the best way to prepare for future pandemics. Success requires unprecedented coordination of all actors. WHO is, of course, a key player and its Academy will be an essential platform for disseminating learning.”

WHO Academy, Lyon, France

A 3D rendering of the exterior of the WHO Academy in Lyon, France. © ateliers 2/3/4/

The Academy aims to expand access to critical learning to health workers, managers, public health officials, educators, researchers, policy makers and people who provide care in their own homes and communities, as well as to WHO’s own workforce throughout the world. The vast majority will use online means to access the Academy’s programmes, which will be made available via desktop and mobile devices and in low-bandwidth settings, thereby ensuring an equitable, global and diverse cohort of learners.

Additionally, the WHO Academy will:

  • Harness the capabilities of new, high-impact technologies such as virtual reality, augmented reality, artificial intelligence and serious educational games to deliver health learning for maximum impact.
  • Formally recognize the competencies gained by learners through “digital credentials” that they can show to employers and regulatory agencies to help advance their careers.
  • Offer more than 100 major learning programmes by 2023, with flagship credentialed programmes for COVID-19 Vaccine Equity, Universal Health Coverage, Health Emergencies and Healthier Lives. The Academy will also offer its learners streamlined access to WHO’s full breadth of hundreds of e-learning programmes currently spread over 20 digital learning platforms as well as access to high quality learning programmes developed by others.

 

WHO Academy’s Executive Director

WHO also used the occasion to announce the appointment, which became effective on 16 August 2021, of Dr Agnès Buzyn as the Academy’s Executive Director. She has been serving since January as the WHO Director-General’s Envoy for Multilateral Affairs, during which time she has also supervised the Academy project.

Lead investor

As a WHO Member State and a key actor in global health, France is the lead investor in the Academy’s development, having committed more than €120 million to support its establishment and infrastructure. This achievement is possible thanks to the collective actions, commitment and financial support of the City of Lyon and the Lyon Metropole, as well as from the Auvergne-Rhône-Alpes region, which contributed €25 million of the total investment. The region will own the campus and lease it to WHO.

 

 

 

 

https://interhospi.com/wp-content/uploads/sites/3/2021/09/who_academy_Lyon_web.jpg 768 1417 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-27 14:42:262021-09-27 14:42:26Macron, Ghebreyesus break ground for new WHO Academy in Lyon

FDA approves first interchangeable biosimilar insulin product for treatment of diabetes

, 22 September 2021/in E-News /by 3wmedia

The US FDA has approved the first interchangeable biosimilar insulin product, indicated to improve glycaemic control in adults and paediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/semglee.jpg 1225 2201 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-09-22 09:17:292021-09-22 09:17:29FDA approves first interchangeable biosimilar insulin product for treatment of diabetes

Researchers establish novel approach for developing new antibiotics

, 22 September 2021/in E-News /by panglobal

Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a novel method for producing new antibiotics to combat resistant bacteria. Through an approach that would target bacteria with an antibiotic that is masked by a prodrug, which the bacteria would themselves remove, the researchers identified a method that would allow for development of new, effective […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/Audrey-Odom-John.jpg 516 390 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-22 09:01:442021-09-22 09:12:33Researchers establish novel approach for developing new antibiotics

Scientists test customized wound dressings made from tropoelastin

, 22 September 2021/in E-News /by panglobal

Customized, biomedically applicable materials based on tropoelastin are being developed in a joint project by Skinomics from Halle, Martin Luther University Halle-Wittenberg and the Fraunhofer Institute for Microstructure of Materials and Systems IMWS. The material combines biocompatibility, durability, biodegradability and favourable mechanical properties similar to those of skin. Preclinical tests have confirmed that it is […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/fraunhoffer_tropoelastin.jpg 1388 2080 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-22 08:54:292021-09-22 08:54:29Scientists test customized wound dressings made from tropoelastin

Researchers find gene therapy provides neuroprotection to prevent glaucoma vision loss

, 22 September 2021/in E-News /by panglobal

A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH’s National Eye Institute. The findings suggest a way forward for developing neuroprotective therapies for glaucoma, a leading cause of visual impairment and blindness. The report was published in Cell [1].

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/eye.jpg 762 1594 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-22 08:47:172021-09-22 08:47:17Researchers find gene therapy provides neuroprotection to prevent glaucoma vision loss

Researchers find gene therapy provides neuroprotection to prevent glaucoma vision loss

, 22 September 2021/in E-News /by 3wmedia

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla vulputate condimentum eros. Sed quis luctus leo. Pellentesque pellentesque magna justo, vel ornare purus convallis id. Nunc a libero in sem vehicula pulvinar gravida mattis sem.

Read more
https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2021-09-22 08:39:352021-09-22 08:39:35Researchers find gene therapy provides neuroprotection to prevent glaucoma vision loss

Physicians urged to take note of ethnicity-specific BMI guidelines

, 22 September 2021/in E-News /by panglobal

While body mass index (BMI) as a body composition assessment tool has long had its critics, recent research has highlighted a new potential drawback in that it could prevent people of certain ethnicities from having their risk for Type 2 diabetes assessed earlier. A psychologist and weight management specialist at Cleveland Clinic stresses the importance […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/Dr-Leslie-Heinberg-CCF.jpg 2313 1850 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-22 08:37:532021-09-22 08:41:20Physicians urged to take note of ethnicity-specific BMI guidelines

Global economic recovery slowed by vaccine inequity

, 22 September 2021/in E-News /by panglobal

Covid-19 vaccine inequity will have a lasting and profound impact on socio-economic recovery in low- and lower-middle income countries without urgent action to boost supply and assure equitable access for every country, including through dose sharing, according to new data released recently by the United Nations Development Programme (UNDP), the World Health Organization (WHO) and […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/covid_vaccine-scaled.jpg 1440 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-22 08:29:312021-09-22 08:29:31Global economic recovery slowed by vaccine inequity

Jürgen Semmler appointed new managing director at Shimadzu Europe

, 21 September 2021/in E-News /by panglobal

Shimadzu, one of the world leaders in analytical instrumentation, has appointed Jürgen Semmler as the new managing director of its European organization from July 1, 2021. Previously, head of Shimadzu Deutschland, he succeeds Jürgen Kwass, who led Shimadzu Europa from 2003 to the present and is now retiring. Semmler and Kwass have both been affiliated […]

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/Shimadzu_Jürgen-Semmler.jpg 984 904 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 13:09:102021-09-21 13:09:10Jürgen Semmler appointed new managing director at Shimadzu Europe

Medovate expands SAFIRA product range with further CE Mark approvals

, 21 September 2021/in E-News /by panglobal

Medovate has successfully secured additional CE Mark approvals for its SAFIRA (SAFer Injection for Regional Anaesthesia) technology to include an NRFit syringe and a Palm Operator

Read more
https://interhospi.com/wp-content/uploads/sites/3/2021/09/medovate_NRFit-scaled.jpg 1706 2560 panglobal https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png panglobal2021-09-21 13:04:592021-09-21 13:11:36Medovate expands SAFIRA product range with further CE Mark approvals
Page 47 of 231«‹4546474849›»

Latest issue of International Hospital

April 2024

4 July 2025

Everdrone expands world-first medical emergency drone network in Sweden

4 July 2025

Wireless implant breakthrough offers personalised chronic pain relief

3 July 2025

EEG-powered brain computer interface enables finger-level robotic hand control

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription